These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12615821)

  • 21. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
    Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
    Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype.
    Tok EC; Aktas A; Ertunc D; Erdal EM; Dilek S
    Hum Reprod; 2005 Jun; 20(6):1590-5. PubMed ID: 15705622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the angiotensin converting enzyme gene insertion/deletion polymorphism and metabolic disturbances in women with polycystic ovary syndrome.
    Ożegowska K; Bogacz A; Bartkowiak-Wieczorek J; Seremak-Mrozikiewicz A; Pawelczyk L
    Mol Med Rep; 2016 Dec; 14(6):5401-5407. PubMed ID: 27840997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Pro12Ala polymorphism of the PPAR-gamma gene is not associated with the polycystic ovary syndrome.
    Xita N; Lazaros L; Georgiou I; Tsatsoulis A
    Hormones (Athens); 2009; 8(4):267-72. PubMed ID: 20045799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
    Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndrome.
    He J; Wang L; Liu J; Liu F; Li X
    J Assist Reprod Genet; 2012 Jul; 29(7):669-77. PubMed ID: 22527903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
    San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
    Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome.
    Sóter MO; Ferreira CN; Sales MF; Candido AL; Reis FM; Milagres KS; Ronda C; Silva IO; Sousa MO; Gomes KB
    Cytokine; 2015 Dec; 76(2):227-235. PubMed ID: 26141422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of the peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha genes in Chinese women with polycystic ovary syndrome.
    Wang Y; Wu X; Cao Y; Yi L; Fan H; Chen J
    Fertil Steril; 2006 May; 85(5):1536-40. PubMed ID: 16600233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP1A1 polymorphism in adolescents with polycystic ovary syndrome.
    Akgül S; Derman O; Alikaşifoğlu M; Aktaş D
    Int J Gynaecol Obstet; 2011 Jan; 112(1):8-10. PubMed ID: 20965504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome.
    Kim JJ; Choi YM; Hong MA; Hwang SS; Yoon SH; Chae SJ; Jee BC; Ku SY; Kim JG; Moon SY
    Hum Reprod; 2009 May; 24(5):1184-90. PubMed ID: 19218574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis.
    Tang ST; Wang CJ; Tang HQ; Peng WJ; Wang YM; Zhang Q
    Mol Biol Rep; 2012 Oct; 39(10):9649-60. PubMed ID: 22729915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels.
    Xita N; Tsatsoulis A; Chatzikyriakidou A; Georgiou I
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5976-80. PubMed ID: 14671199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for gene-nutrient interaction at the PPARgamma locus.
    Luan J; Browne PO; Harding AH; Halsall DJ; O'Rahilly S; Chatterjee VK; Wareham NJ
    Diabetes; 2001 Mar; 50(3):686-9. PubMed ID: 11246892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.
    El-Shal AS; Zidan HE; Rashad NM; Abdelaziz AM; Harira MM
    IUBMB Life; 2016 Jan; 68(1):23-36. PubMed ID: 26662070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of polycystic ovary syndrome (PCOS) associated with CC genotype of miR-146a gene variation.
    Ebrahimi SO; Reiisi S; Parchami Barjui S
    Gynecol Endocrinol; 2018 Sep; 34(9):793-797. PubMed ID: 29637801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
    Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Calpain (CAPN) 10 (UCSNP-43, rs3792267) gene polymorphism with elevated serum androgens in young women with the most severe phenotype of polycystic ovary syndrome (PCOS).
    Anastasia K; Koika V; Roupas ND; Armeni A; Marioli D; Panidis D; George A; Georgopoulos NA
    Gynecol Endocrinol; 2015; 31(8):630-4. PubMed ID: 26376770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CC genotype of the GNAS T393C polymorphism is associated with obesity and insulin resistance in women with polycystic ovary syndrome.
    Hahn S; Frey UH; Siffert W; Tan S; Mann K; Janssen OE
    Eur J Endocrinol; 2006 Nov; 155(5):763-70. PubMed ID: 17062894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.